Return on Tangible Equity: The amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity. Calculated as: Income from Continuing Operations / Tangible Shareholders Equity
Hepion Pharmaceuticals, Inc. (HEPA) had Return on Tangible Equity of -156.72% for the most recently reported fiscal quarter, ending 2025-03-31.
| Income Statement Financials | |
-- |
|
$-6.11M |
|
-- |
|
-- |
|
$1.28M |
|
$-1.28M |
|
$-4.83M |
|
$-6.11M |
|
$-6.11M |
|
$-6.11M |
|
$-6.11M |
|
$-6.11M |
|
$-6.11M |
|
$-1.28M |
|
$-1.28M |
|
2.84M |
|
2.84M |
|
$-2.15 |
|
$-2.15 |
|
| Balance Sheet Financials | |
$6.32M |
|
-- |
|
-- |
|
$6.32M |
|
$0.94M |
|
-- |
|
$1.49M |
|
$2.42M |
|
$2.20M |
|
$3.90M |
|
$3.90M |
|
9.59M |
|
| Cash Flow Statement Financials | |
$-1.12M |
|
-- |
|
$5.30M |
|
$0.41M |
|
$4.59M |
|
$4.18M |
|
$0.02M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
6.75 |
|
-- |
|
-- |
|
-- |
|
0.14 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-1.12M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-277.42% |
|
|
Return on Tangible Equity |
-156.72% |
-96.63% |
|
-156.72% |
|
$0.41 |
|
$-0.39 |
|
$-0.39 |
|